Indivior Share News (INDV)

Indivior extends deal with investor Scopia to keep boardmember Jerome Lande

(Sharecast News) - Pharma group Indivior has extended its deal with shareholder Scopia Capital Management that will see the latter's representative Jerome Lande stay on the board until the end of next year.

LONDON MARKET CLOSE: Stocks close up on busy corporate day

(Alliance News) - Stock prices in London closed higher on Thursday, after a "mixed bag" of company updates and earnings.

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Indivior swings to quarterly loss on costs despite strong sales

(Alliance News) - Indivior PLC on Thursday maintained net revenue guidance, after swinging to a net loss despite seeing a sales increase in the third quarter.

Indivior swings to loss despite strong Sublocade performance

(Sharecast News) - Indivior reported a solid third-quarter financial performance on Thursday, as Sublocade net revenue jumped 55% year-on-year to $167m, although a significant cash outflow saw it swing to a loss.

UK earnings, trading statements calendar - next 7 days

LONDON BROKER RATINGS: Barclays ups Rio Tinto; Liberum likes Indivior

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

London close: Stocks mixed at start of busy week

(Sharecast News) - London's stock markets finished with a varied performance on Monday, driven by concerns over rising UK bond yields and global interest rate trends.

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

LONDON MARKET OPEN: Keller jumps; Mission sinks on profit warning

(Alliance News) - Stock prices in London opened lower on Monday, while oil and gold prices fell, as tensions in the Middle East continue to shake markets.

TOP NEWS: Indivior pays USD385 million to end Suboxone antitrust case

(Alliance News) - Indivior PLC on Monday said it has reached an agreement to settle a US multi-district Suboxone litigation case, forking out USD385 million in the process.

Indivior to pay $385m to settle multi-district Suboxone case

(Sharecast News) - Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.

LONDON MARKET CLOSE: FTSE 100 tips into red as housebuilders struggle

(Alliance News) - Stocks in London were lower at the close on Monday, with the FTSE 100 tipping into the red as its blue-chip housebuilders were hurt by less-than-stellar data from Rightmove and a profit warning from FTSE 250 peer Crest Nicholson.

LONDON MARKET MIDDAY: Crest Nicholson warning hits housing shares

(Alliance News) - Stock prices in London were mixed at midday Monday, after a profit warning from Crest Nicholson, as well as some poor data from Rightmove, rattled stocks in the housebuilding sector.

Indivior to settle litigation with USD30 million payment to claimants

(Alliance News) - Indivior PLC on Monday announced it is resolving claims brought in antitrust multi-district litigation regarding its drug Suboxone by paying claimants millions of dollars.